(주)엑소좀플러스

{
  "address": "경상북도 포항시",
  "ceo_name": "박재성",
  "certificate": [
    {
      "cert_number": "20180112147",
      "changes": "",
      "disclosure_date": "2018-10-24",
      "first_cert_date": "2018-10-24",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-10-24 ~ 2020-10-23"
    },
    {
      "cert_number": "20200114718",
      "changes": "",
      "disclosure_date": "2020-11-12",
      "first_cert_date": "2018-10-24",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2020-10-24 ~ 2022-10-23"
    },
    {
      "cert_number": "20221123020037",
      "changes": "",
      "disclosure_date": "2022-11-23",
      "first_cert_date": "2018-10-24",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2022-10-24 ~ 2025-10-23"
    },
    {
      "cert_number": "20251105010021",
      "changes": "",
      "disclosure_date": "2025-11-05",
      "first_cert_date": "2018-10-24",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2025-10-24 ~ 2028-10-23"
    }
  ],
  "company_name": "(주)엑소좀플러스",
  "corp_no": "110111-*******",
  "financials": {
    "2023": {
      "capital_stock": 107289000,
      "cost_of_sales": 82461000,
      "current_assets": 135243000,
      "current_liabilities": 53589000,
      "gross_profit": 233770000,
      "net_income": 41546000,
      "net_income_bs": 41546000,
      "non_current_assets": 90274000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 14153000,
      "non_operating_income": 43560000,
      "operating_profit": 12139000,
      "revenue": 316231000,
      "sga_expenses": 221631000,
      "total_assets": 225516000,
      "total_equity": 171928000,
      "total_liabilities": 53589000
    },
    "2024": {
      "capital_stock": 107289000,
      "cost_of_sales": 41839000,
      "current_assets": 45964000,
      "current_liabilities": 13056000,
      "gross_profit": 40346000,
      "net_income": -96351000,
      "net_income_bs": -96351000,
      "non_current_assets": 42669000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 1512000,
      "non_operating_income": 1744000,
      "operating_profit": -96583000,
      "revenue": 82185000,
      "sga_expenses": 136929000,
      "total_assets": 88633000,
      "total_equity": 75577000,
      "total_liabilities": 13056000
    },
    "2025": {
      "capital_stock": 107289000,
      "cost_of_sales": 1386000,
      "current_assets": 28184000,
      "current_liabilities": 10925000,
      "gross_profit": 5896000,
      "net_income": -15650000,
      "net_income_bs": -15650000,
      "non_current_assets": 42669000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 15000,
      "operating_profit": -15665000,
      "revenue": 7283000,
      "sga_expenses": 21562000,
      "total_assets": 70852000,
      "total_equity": 59927000,
      "total_liabilities": 10925000
    }
  },
  "industry": "그 외 기타 분류 안된 화학제품 제조업",
  "investment": [
    {
      "amount": "1,000,008,000",
      "changes": "1,000,008,000",
      "date": "2019-02-25"
    }
  ],
  "main_products": "신장치료제 황반변성치료제",
  "phone": "054-279-****",
  "years": [
    2025,
    2024,
    2023
  ]
}